Should chemotherapy in neoadjuvant setting in node positive breast cancers be guided by biology over magnitude of tumour burden?

Subjects

Subjects :

Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
Node (networking)
medicine.medical_treatment
Internal medicine
medicine
Biology

Details

ISSN :

09598049

Volume :

138

Database :

OpenAIRE

Journal :

European Journal of Cancer

Accession number :

edsair.doi...........87234ccdeb052f93ba5d87214211fe1e

Full Text :

https://doi.org/10.1016/s0959-8049(20)30676-6